NEW YORK (GenomeWeb) – CombiMatrix said today that it has entered into a contractual agreement with Fortified Provider Network for coverage of CombiMatrix's suite of diagnostic laboratory services.
FPN has more than 200 payor clients nationwide and contracts with physicians, hospitals, ancillary facilities, mid-level providers, and other specialty healthcare providers who have the option of participating in one or more of its products.
"Our contract with Fortified Provider Network is a result of our continued focus on executing our third-party payor strategy to deliver microarray technologies to doctors and patients nationwide," CombiMatrix President and CEO Mark McDonough said in a statement.
"This contract enables us to offer our suite of diagnostic services, including CombiSNP Microarray Analysis, to the members of FPN, whose ultimate goal is ensure that the end-user patients are able to receive excellent care in the location of their choice from high-quality providers, all at a cost that is both acceptable and attractive to their payor clients and providers," McDonough added.